Mount Sinai is introducing a program for Crohn's disease patients that joins traditional biologic therapy with a finely tuned program of brain-gut behavior therapy focused on building resilience in patients intent on controlling their disease.
Mount Sinai is introducing a program for Crohn's disease patients that joins traditional biologic therapy with a finely tuned program of brain-gut behavior therapy focused on building resilience in patients intent on controlling their disease.